Reduced-intensity delayed intensification in standard-risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: results of an international randomized trial (AIEOP-BFM ALL 2000) - Schrappe, Martin; Bartram, Claus R. (Journal of clinical oncology, 2018)
Published at jco.orgon November 17, 2017